ResMed
VC Fund
San Diego, United States
ResMed is a VC fund in San Diego focused on Health Care and Medical. At ResMed we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platformssupport the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 29%
Last updated:
For AI agents: llms.txt
Industries ResMed invests in
Stages ResMed invests in
Countries ResMed invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 12 contacts → | |||
Investment Focus
Industry
- Health Care 6 (86%)
- Medical 3 (43%)
- Medical Device 3 (43%)
- Artificial Intelligence 3 (43%)
- Therapeutics 2 (29%)
Stage
- Seed 1 (14%)
- Grant 1 (14%)
- Series B 1 (14%)
- Series C 1 (14%)
- Corporate Round 1 (14%)
Country
- United States 4 (57%)
- Ireland 2 (29%)
- Belgium 1 (14%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Andrew Huxter
VP Northern Europe & Growth Markets EMEA
|
VP Northern Europe & Growth Markets EMEA | Total investments: 0 | Find email | |
Brett Sandercock
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
|
David Greatorex
Founding Investor
|
Founding Investor | Total investments: 1 | Find email | |
Peter Farrell
Founder and Chair Emeritus
|
Founder and Chair Emeritus | Total investments: 4 | Find email | |
Aaron Bloomer
CFO, Principal Financial Officer and Principal Accounting Officer
|
CFO, Principal Financial Officer and Principal Accounting Officer | Total investments: 0 | Find email | |
| See all 12 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Noctrix Health
|
Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness. | $40M / Series C / Jan 16, 2024 | |
Candlelit Care
|
Candlelit Care empowers Black women to best understand their struggles and seek the care they need. We leverage clinical research on perinatal mood disorders and AI to enable quicker access to mental health screening and treatment for Black women and women of color trying to conceive, currently pregnant or recovering from labor. In partnershipwith birth workers, we help women living in maternity care deserts at risk of stress, depression and anxiety achieve health equity through app-based symptom triage, industry-leading perinatal mental health coaching and education at the point-of-care.Candlelit Care is backed by passionate investors who share in our mission to radically address the Black maternal health crisis in the U.S., including MedTech Color, Springboard Enterprises, CUNY School of Public Health, Cedars Sinai Technology Ventures, Techstars Impact powered by Cox Enterprises. Candlelit Care was founded in 2019 and is headquartered in Charlotte, NC. | $25K / Non-equity Assistance / Mar 08, 2023 | |
Medihive
|
Medihive offers a sophisticated range of clinical solutions and software. In order to provide customers and their end users with high-quality virtual care, Medihive integrates digital and clinical expertise. | $7.6M / Venture - Series Unknown / Jan 27, 2023 | |
curie ai
|
Curie AI is a tech-enabled respiratory care company providing virtual personalized disease management through proprietary AI that passively detects symptoms. This approach results in high adherence, reduction in adverse events, cost savings, and improving overall quality of life for people with chronic respiratory conditions | Seed / Apr 12, 2022 | |
Samay
|
Respira Labs is developing the first wearable device to measure “trapped air,” an early marker of Chronic Obstructive Pulmonary Disease (COPD). No reliable and validated methods currently exist to detect COPD exacerbations in time for early intervention and prevention. By leveraging the power of non-invasive acoustic sensors, audio signalprocessing, machine learning and Acoustic Resonance Index Analysis (ARIA), our device will fundamentally revolutionize COPD management by predicting and preventing attacks at the patient’s home, significantly improving health outcomes and patient quality of life while dramatically lowering health care costs. | $25K / Grant / Mar 23, 2021 | |
Nyxoah
|
Nyxoah is a health-technology company focused on the development and commercialization of innovative solutions and services to treat sleep disordered breathing conditions. Nyxoah's lead solution platform is based on the Genio® system, a validated, user-centered, next generation neurostimulation therapy for OSA, the world's most commonsleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke. | $27.2M / Corporate Round / Feb 12, 2020 | |
BiancaMed
|
BiancaMed's vision is to help people enjoy healthy lives. BiancaMed offers leading health technology solutions for monitoring everyday living. Increasing healthcare costs coupled with the rise in chronic conditions, increasing obesity and the rapid aging of the population, suggests that health management will need to shift fromtraditional institutional settings (such as hospitals) to people's everyday environments, including the home.BiancaMed's mission is to transform personal health by providing the ultimate convenience in personal health monitoring. At the core of our product platform is a very sensitive motion sensor that detects heart rate and respiration - without having to touch a person - completely wirelessly. | $8.7M / Series B / Sep 15, 2009 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does ResMed invest in?
ResMed invests primarily in Health Care, Medical and Medical Device startups, most often at Seed and Grant stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact ResMed?
Public channels for ResMed include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at ResMed?
The team at ResMed includes Andrew Huxter (VP Northern Europe & Growth Markets EMEA), Brett Sandercock (Chief Financial Officer) and David Greatorex (Founding Investor), among 12 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
